Brief: Exosens FY Adjusted EBITDA Up 37.8% To EUR 118.5 Million
03/03/2025 06:41
March 3 (Reuters) - Exosens SAS EXENS.PA: FY 2024 REVENUE GROWS 35% TO €394.1M FY 2024 NET PROFIT UP 66.7% TO €30.7M CONTINUED STRONG PERFORMANCE EXPECTED IN 2025, WITH REVENUE GROWTH IN THE HIGH-TEENS AND ADJUSTED EBITDA GROWTH IN THE LOW TWENTIES FY 2024 ADJUSTED EBITDA UP 37.8% TO €118.5M NET LEVERAGE AT 1.2X YEAR-END 2024 PROPOSES €0.10 CASH DIVIDEND PER SHARE FOR FY 2024 TO INVEST €20M TO EXPAND PRODUCTION CAPACITY IN EUROPE, US WITH NEW PRODUCTION PLANT IN THE US, TO GIVE ADDITIONAL MARKET OPPORTUNITIES HIGH-TEENS 2024-2026 ADJUSTED EBITDA CAGR Source text: ID:nGNE1K7w17 Further company coverage: EXENS.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))